Skip to main content

Loading market data...

OGN

Organon & Co.

NYSE • United states

$13.75

-$0.01

(-0.07%)

Source: Yahoo Finance · Quote time Oct 21, 2026 20:00 GMT+0000

Management
Credibility
Score

Organon & Co. (OGN)

Unavailable

Quotes may be delayed

$3.61B

Market Cap

2,555,471

Volume

17.3

P/E Ratio

0.58%

Div Yield

Organon & Co. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 30 HUDSON STREET, JERSEY CITY, NJ
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

14 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Organon & Co..

31 Jul 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in Organon & Co..

31 Jul 2026

Organon & Co. reported Regulation FD disclosure

Organon & Co. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

31 Jul 2026

Organon & Co. filed Form 10-Q

Organon & Co. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

23 Jul 2026

Organon & Co. reported Shareholder voting results

Organon & Co. filed an 8-K covering shareholder voting results.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$1.13B

Total assets (USD)$13.18B

Total liabilities (USD)$12.17B

Shareholders' equity (USD)$1.01B

Long-term debt (USD)$8.48B

Debt due within a year (USD)$74.00M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$1.56B	Unavailable	$108.00M	$0.40	10-Q · 31 Jul 2026
Q1 2026	$1.46B	Unavailable	$146.00M	$0.55	10-Q · 4 May 2026
Q4 2025	$1.51B	Unavailable	−$205.00M	Unavailable	10-K · 24 Feb 2026
Q3 2025	$1.60B	Unavailable	$160.00M	$0.61	10-Q · 10 Nov 2025
Q2 2025	$1.59B	Unavailable	$145.00M	$0.56	10-Q · 6 Aug 2025
Q1 2025	$1.51B	Unavailable	$87.00M	$0.33	10-Q · 2 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Analyst Consensus Unavailable

No reliable analyst consensus source returned data for this stock.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

11

Aug 2026

Arjona Ferreira Juan Camilo

Head of R&D & CMO

Option exercise

Unavailable per share

11,519 shares

11

Aug 2026

Arjona Ferreira Juan Camilo

Head of R&D & CMO

Tax withholding

$13.62 per share

4,134 shares

5

Aug 2026

Drinane Juliana Papa

Head of Mfg & Supply

Open-market sale

$13.57 per share

14,761 shares

Top Shareholders

Vanguard Group Inc

36,916,382 shares

2.75% change

12/31/2025

Blackrock, Inc.

32,056,866 shares

1.071% change

6/30/2026

Pentwater Capital Management Lp

18,100,000 shares

New% change

6/30/2026

Vanguard Portfolio Management Llc

15,132,118 shares

-30.733% change

6/30/2026

Vanguard Capital Management Llc

11,909,865 shares

1.473% change

6/30/2026

State Street Corp

9,659,371 shares

-2.987% change

6/30/2026

Goldman Sachs Group Inc

5,199,002 shares

223.86% change

6/30/2026

Ubs Group Ag

4,856,529 shares

39.894% change

6/30/2026

Geode Capital Management, Llc

4,815,610 shares

1.182% change

6/30/2026

Alliancebernstein L.P.

4,754,671 shares

559.902% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 22 Oct 2026, 02:47 UTC· 4 hours ago

Research coverage and investment tools

Organon & Co. (OGN) is a stock listed on the New York Stock Exchange in the United States, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its last price was US$13.75 on 21 Oct 2026. That is 99% of the way from its 52-week low of US$5.69 to its 52-week high of US$13.83. It paid US$0.0800 a share in dividends over the last 12 months, a dividend yield of 0.58%. The latest ex-dividend date on file is 14 Aug 2026. Its market capitalisation was US$3.61 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$1.56B	Unavailable	$108.00M	$0.40	54.4%	—	$65.00M	10-Q · 31 Jul 2026 (opens in a new tab)
Q1 2026	$1.46B	Unavailable	$146.00M	$0.55	53.6%	—	$188.00M	10-Q · 4 May 2026 (opens in a new tab)
Q4 2025	$1.51B	Unavailable	−$205.00M	Unavailable	49.2%	—	$96.00M	10-K · 24 Feb 2026 (opens in a new tab)
Q3 2025	$1.60B	Unavailable	$160.00M	$0.61	53.5%	—	$218.00M	10-Q · 10 Nov 2025 (opens in a new tab)
Q2 2025	$1.59B	Unavailable	$145.00M	$0.56	54.8%	—	$181.00M	10-Q · 6 Aug 2025 (opens in a new tab)
Q1 2025	$1.51B	Unavailable	$87.00M	$0.33	55.6%	—	$43.00M	10-Q · 2 May 2025 (opens in a new tab)

Quarter ended	Reported	EPS	Consensus	Surprise
Jun 2026	7/31/2026	$0.80	$0.85	-5.9%
Mar 2026	4/30/2026	$0.66	$0.82	-19.5%
Dec 2025	2/12/2026	$0.61	$0.70	-12.9%
Sep 2025	11/10/2025	$0.93	$0.90	+3.3%

Cash and equivalents: $1.13B
Total assets: $13.18B
Total liabilities: $12.17B
Shareholders' equity: $1.01B
Long-term debt: $8.48B
Debt due within a year: $74.00M

SCHEDULE 13G · 14 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Organon & Co..
SCHEDULE 13G/A · 31 Jul 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in Organon & Co..
8-K · 31 Jul 2026

Organon & Co. reported Regulation FD disclosure (opens in a new tab)

Organon & Co. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.
10-Q · 31 Jul 2026

Organon & Co. filed Form 10-Q (opens in a new tab)

Organon & Co. submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 23 Jul 2026

Organon & Co. reported Shareholder voting results (opens in a new tab)

Organon & Co. filed an 8-K covering shareholder voting results.

Insider	Date	Transaction	Shares	Average price	Filing
Arjona Ferreira Juan Camilo Head of R&D & CMO	11 Aug 2026	Option exercise (M)	+11,519	—	Form 4 (opens in a new tab)
Arjona Ferreira Juan Camilo Head of R&D & CMO	11 Aug 2026	Tax withholding (F)	−4,134	$13.62	Form 4 (opens in a new tab)
Drinane Juliana Papa Head of Mfg & Supply	5 Aug 2026	Open-market sale (S)	−14,761	$13.57	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	36,916,382	2.75%
Blackrock, Inc.	6/30/2026	32,056,866	1.071%
Pentwater Capital Management Lp	6/30/2026	18,100,000	New
Vanguard Portfolio Management Llc	6/30/2026	15,132,118	-30.733%
Vanguard Capital Management Llc	6/30/2026	11,909,865	1.473%
State Street Corp	6/30/2026	9,659,371	-2.987%
Goldman Sachs Group Inc	6/30/2026	5,199,002	223.86%
Ubs Group Ag	6/30/2026	4,856,529	39.894%
Geode Capital Management, Llc	6/30/2026	4,815,610	1.182%
Alliancebernstein L.P.	6/30/2026	4,754,671	559.902%

Previous close: 13.76 USD
Day range: 13.74 – 13.77 USD
52-week range: 5.69 – 13.83 USD
Volume: 2,555,471
Market cap: $3.61B
P/E ratio: 17.3
EPS (FY 2025, diluted): 0.72 USD
Dividends (last 12 months): 0.08 USD
Dividend yield: 0.58%
Ex-dividend date: 14 Aug 2026
Shares outstanding: 262.61M
Beta (5Y monthly): 1.52

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 21 Oct 2026, 20:00 UTC· 11 hours ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 06:32 UTC· 43 minutes ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 06:32 UTC· 43 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for OGN yet

Analyst consensus
Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.